Table 4.
Cancer mortality in Aboriginal males, NSW, 1999-2007, and risk comparison with non-Aboriginal males
| Mortality rate1 per 100,000 (95% CI) | Risk3 to age 75, 1 in: | ||||
|---|---|---|---|---|---|
| Cancer site |
Deaths |
|
SMR2 (95% CI) |
Aboriginal |
Non-Aboriginal |
| Head and neck |
54 |
20.6 (14.5-28.0) |
3.18 (2.39-4.15) |
56 |
155 |
| Oesophagus |
25 |
12.9 (7.6-20.1) |
2.31 (1.50-3.42) |
86 |
241 |
| Stomach |
34 |
21.2 (13.5-31.1) |
2.09 (1.45-2.92) |
71 |
165 |
| Large bowel |
68 |
38.6 (28.0-51.2) |
1.40 (1.08-1.77) |
45 |
52 |
| Liver |
20 |
7.8 (4.2-12.8) |
1.74 (1.06-2.68) |
135 |
250 |
| Pancreas |
30 |
19.0 (11.6-28.7) |
1.70 (1.15-2.42) |
94 |
147 |
| Lung |
164 |
91.1 (75.3-108.8) |
1.99 (1.69-2.31) |
14 |
29 |
| Melanoma of skin |
12 |
8.1 (3.5-15.0) |
0.67 (0.35-1.17) |
174 |
173 |
| Prostate |
65 |
57.1 (42.6-74.5) |
1.86 (1.43-2.37) |
51 |
86 |
| Kidney |
19 |
10.5 (5.4-17.8) |
1.70 (1.02-2.66) |
159 |
254 |
| Bladder |
10 |
7.3 (2.8-14.6) |
1.12 (0.54-2.06) |
366 |
316 |
| Brain |
14 |
4.4 (1.7-8.4) |
0.76 (0.42-1.28) |
346 |
191 |
| Non-Hodgkin’s lymphoma |
18 |
7.9 (4.0-13.6) |
1.09 (0.64-1.72) |
169 |
176 |
| All leukaemias |
27 |
16.0 (9.3-25.1) |
1.44 (0.95-2.10) |
115 |
185 |
| Unknown primary |
48 |
25.1 (17.1-35.0) |
1.86 (1.37-2.46) |
57 |
106 |
| All cancers | 657 | 372.9 (338.9-409.0) | 1.68 (1.55-1.81) | 4.7 | 7.5 |
1Directly age-standardised to 2001 Australian census population.
2Standardised mortality ratio in relation to all NSW males.
3Cumulative risk.